Detalhe da pesquisa
1.
Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials.
Blood
; 139(11): 1684-1693, 2022 03 17.
Artigo
Inglês
| MEDLINE | ID: mdl-34614146
2.
Lack of reproducibility of histopathological features in MYC-rearranged large B cell lymphoma using digital whole slide images: a study from the Lunenburg lymphoma biomarker consortium.
Histopathology
; 82(7): 1105-1111, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-36849712
3.
Personalised therapy in follicular lymphoma - is the dial turning?
Hematol Oncol
; 2023 Jul 22.
Artigo
Inglês
| MEDLINE | ID: mdl-37482955
4.
Clinical characteristic and outcome of lymphoplasmacytic lymphoma of non-Waldenstrom macroglobulinemia type: A Swedish lymphoma registry study.
Br J Haematol
; 196(6): 1362-1368, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34959252
5.
Prognostic value of POD24 validation in follicular lymphoma patients initially treated with chemotherapy-free regimens in a pooled analysis of three randomized trials of the Swiss Group for Clinical Cancer Research (SAKK).
Br J Haematol
; 192(6): 1031-1034, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32805081
6.
Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy.
Blood
; 134(4): 353-362, 2019 07 25.
Artigo
Inglês
| MEDLINE | ID: mdl-31101627
7.
The simplified follicular lymphoma PRIMA-prognostic index is useful in patients with first-line chemo-free rituximab-based therapy.
Br J Haematol
; 191(5): 738-747, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32410260
8.
M7-FLIPI is not prognostic in follicular lymphoma patients with first-line rituximab chemo-free therapy.
Br J Haematol
; 188(2): 259-267, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31423576
9.
Prognostic implications of the microenvironment for follicular lymphoma under immunomodulation therapy.
Br J Haematol
; 189(4): 707-717, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32012230
10.
High-risk chronic lymphocytic leukemia in the era of pathway inhibitors: integrating molecular and cellular therapies.
Blood
; 132(9): 892-902, 2018 08 30.
Artigo
Inglês
| MEDLINE | ID: mdl-29997221
11.
Absolute B cell counts in blood predict long-term response in follicular lymphoma patients treated with rituximab without chemotherapy.
Ann Hematol
; 99(10): 2357-2366, 2020 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-32808106
12.
First-line therapy in chronic lymphocytic leukemia: a Swedish nation-wide real-world study on 1053 consecutive patients treated between 2007 and 2013.
Haematologica
; 104(4): 797-804, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30467205
13.
Prognostic factors and primary treatment for Waldenström macroglobulinemia - a Swedish Lymphoma Registry study.
Br J Haematol
; 183(4): 564-577, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30198549
14.
Ibrutinib induces rapid down-regulation of inflammatory markers and altered transcription of chronic lymphocytic leukaemia-related genes in blood and lymph nodes.
Br J Haematol
; 183(2): 212-224, 2018 10.
Artigo
Inglês
| MEDLINE | ID: mdl-30125946
15.
Treatment recommendations from the Eighth International Workshop on Waldenström's Macroglobulinemia.
Blood
; 128(10): 1321-8, 2016 09 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27432877
16.
Career development: A balance of opportunities and choices.
Hematol Oncol
; 2023 Jun 02.
Artigo
Inglês
| MEDLINE | ID: mdl-37269162
17.
Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years.
Biol Blood Marrow Transplant
; 23(3): 428-435, 2017 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-28039078
18.
Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome.
Haematologica
; 102(1): 43-51, 2017 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27758817
19.
Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium.
Haematologica
; 102(8): 1413-1423, 2017 08.
Artigo
Inglês
| MEDLINE | ID: mdl-28411252
20.
Health-related quality of life and symptoms in patients with rituximab-refractory indolent non-Hodgkin lymphoma treated in the phase III GADOLIN study with obinutuzumab plus bendamustine versus bendamustine alone.
Ann Hematol
; 96(2): 253-259, 2017 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-27900446